Oncology Program

Director: Richard Pazdur, M.D.
Team Leader, Project Management Officer: Dianne Spillman

The Oncology Program works with Centers within FDA and with external stakeholders to initiate, develop, co-ordinate, and communicate cross-cutting FDA initiatives in oncology.  The Program's strategic goals are to identify emerging technologies that may speed the development of new therapies for cancer; examine the regulatory implications of such breakthroughs; and devise strategies for consistent, rational alignment of regulatory policy with scientific advances.

Major areas of focus in the program include:

• FDA's Critical Path Initiative

• Pharmacogenomics

• Biomedical Informatics [external link]

• Clinical Trial Design